You have free access to this content

British Journal of Clinical Pharmacology

Cover image for Vol. 59 Issue 5

May 2005

Volume 59, Issue 5

Pages 491–650

  1. Editors’ view

    1. Top of page
    2. Editors’ view
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Pharmacoepidemiology
    8. Therapeutics
    9. Adverse drug effects
    10. Short reports
    11. Book review
    12. Letters to the editors
    1. You have free access to this content
      Biomarkers and surrogate endpoints (pages 491–494)

      J. K. Aronson

      Version of Record online: 19 APR 2005 | DOI: 10.1111/j.1365-2125.2005.02435.x

  2. Review

    1. Top of page
    2. Editors’ view
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Pharmacoepidemiology
    8. Therapeutics
    9. Adverse drug effects
    10. Short reports
    11. Book review
    12. Letters to the editors
    1. You have free access to this content
      Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects (pages 495–510)

      G. J. H. Dumont, S. J. De Visser, A. F. Cohen and J. M. A. Van Gerven

      Version of Record online: 19 APR 2005 | DOI: 10.1111/j.1365-2125.2005.02342.x

      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image
      • image
  3. Pharmacodynamics

    1. Top of page
    2. Editors’ view
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Pharmacoepidemiology
    8. Therapeutics
    9. Adverse drug effects
    10. Short reports
    11. Book review
    12. Letters to the editors
    1. You have free access to this content
      Laser Doppler imager (LDI) scanner and intradermal injection for in vivo pharmacology in human skin microcirculation: responses to acetylcholine, endothelin-1 and their repeatability (pages 511–519)

      Anabelle M. Opazo Saez, Frank Mosel, Jens Nürnberger, U. Rushentsova, Mario Gössl, Anna Mitchell, Rafael F. Schäfers, Thomas Philipp and René R. Wenzel

      Version of Record online: 2 MAR 2005 | DOI: 10.1111/j.1365-2125.2004.02344.x

      • image
      • image
      • image
      • image
      • image
      • image
      • image
    2. You have free access to this content
      Spironolactone reduces brachial pulse wave velocity and PIIINP levels in hypertensive diabetic patients (pages 520–523)

      J. Davies, A. Gavin, M. Band, A. Morris and A. Struthers

      Version of Record online: 2 MAR 2005 | DOI: 10.1111/j.1365-2125.2005.02363.x

    3. You have free access to this content
      Ventilatory responses of healthy subjects to intravenous combinations of morphine and oxycodone under imposed hypercapnic and hypoxaemic conditions (pages 524–535)

      L. A. Ladd, P. C. Kam, D. B. Williams, A. W. E. Wright, M. T. Smith and L. E. Mather

      Version of Record online: 2 MAR 2005 | DOI: 10.1111/j.1365-2125.2005.02368.x

      • image
      • image
      • image
      • image
      • image
  4. Pharmacokinetics

    1. Top of page
    2. Editors’ view
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Pharmacoepidemiology
    8. Therapeutics
    9. Adverse drug effects
    10. Short reports
    11. Book review
    12. Letters to the editors
    1. You have free access to this content
    2. You have free access to this content
      Determination of the bioavailability of gentamicin to the lungs following inhalation from two jet nebulizers (pages 542–545)

      A. I. Al-Amoud, B. J. Clark, K. A. Assi and H. Chrystyn

      Version of Record online: 2 MAR 2005 | DOI: 10.1111/j.1365-2125.2005.02360.x

      • image
    3. You have free access to this content
  5. Pharmacogenetics

    1. Top of page
    2. Editors’ view
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Pharmacoepidemiology
    8. Therapeutics
    9. Adverse drug effects
    10. Short reports
    11. Book review
    12. Letters to the editors
    1. You have free access to this content
      Chlorpropamide 2-hydroxylation is catalysed by CYP2C9 and CYP2C19 in vitro: chlorpropamide disposition is influenced by CYP2C9, but not by CYP2C19 genetic polymorphism (pages 552–563)

      Ji-Hong Shon, Young-Ran Yoon, Min-Jung Kim, Kyoung-Ah Kim, Young-Chae Lim, Kwang-Hyeon Liu, Dong-Hoon Shin, Chung Han Lee, In-June Cha and Jae-Gook Shin

      Version of Record online: 2 MAR 2005 | DOI: 10.1111/j.1365-2125.2005.02364.x

      • image
      • image
      • image
      • image
      • image
      • image
      • image
  6. Pharmacoepidemiology

    1. Top of page
    2. Editors’ view
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Pharmacoepidemiology
    8. Therapeutics
    9. Adverse drug effects
    10. Short reports
    11. Book review
    12. Letters to the editors
    1. You have free access to this content
      Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention (pages 564–573)

      S. Perreault, L. Blais, D. Lamarre, A. Dragomir, D. Berbiche, L. Lalonde, C. Laurier, F. St-Maurice and J. Collin

      Version of Record online: 2 MAR 2005 | DOI: 10.1111/j.1365-2125.2005.02355.x

      • image
      • image
    2. You have free access to this content
      Khat chewing is a risk factor for acute myocardial infarction: a case-control study (pages 574–581)

      A. Al-Motarreb, S. Briancon, N. Al-Jaber, B. Al-Adhi, F. Al-Jailani, M S. Salek and K J. Broadley

      Version of Record online: 2 MAR 2005 | DOI: 10.1111/j.1365-2125.2005.02358.x

  7. Therapeutics

    1. Top of page
    2. Editors’ view
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Pharmacoepidemiology
    8. Therapeutics
    9. Adverse drug effects
    10. Short reports
    11. Book review
    12. Letters to the editors
    1. You have free access to this content
  8. Adverse drug effects

    1. Top of page
    2. Editors’ view
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Pharmacoepidemiology
    8. Therapeutics
    9. Adverse drug effects
    10. Short reports
    11. Book review
    12. Letters to the editors
    1. You have free access to this content
      Ocular side-effects of tolterodine and oxybutynin, a single-blind prospective randomized trial (pages 588–592)

      R. Altan-Yaycioglu, O. Yaycioglu, Y. Aydin Akova, S. Guvel and H. Ozkardes

      Version of Record online: 2 MAR 2005 | DOI: 10.1111/j.1365-2125.2005.02356.x

  9. Short reports

    1. Top of page
    2. Editors’ view
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Pharmacoepidemiology
    8. Therapeutics
    9. Adverse drug effects
    10. Short reports
    11. Book review
    12. Letters to the editors
    1. You have free access to this content
      Pharmacokinetic interaction on valproic acid and recurrence of epileptic seizures during chemotherapy in an epileptic patient (pages 593–597)

      Hiroaki Ikeda, Teruo Murakami, Mikihisa Takano, Tsuguru Usui and Kenji Kihira

      Version of Record online: 2 MAR 2005 | DOI: 10.1111/j.1365-2125.2005.02339.x

      • image
    2. You have free access to this content
      Lack of effect of moderate hepatic impairment on the pharmacokinetics of oral oseltamivir and its metabolite oseltamivir carboxylate (pages 598–601)

      Paul Snell, Nisha Dave, Katie Wilson, Lucy Rowell, Angelica Weil, Lawrence Galitz and Richard Robson

      Version of Record online: 17 FEB 2005 | DOI: 10.1111/j.1365-2125.2005.02340.x

      • image
    3. You have free access to this content
      Fexofenadine pharmacokinetics are associated with a polymorphism of the SLCO1B1 gene (encoding OATP1B1) (pages 602–604)

      Mikko Niemi, Kari T. Kivistö, Ute Hofmann, Matthias Schwab, Michel Eichelbaum and Martin F. Fromm

      Version of Record online: 2 MAR 2005 | DOI: 10.1111/j.1365-2125.2005.02354.x

      • image
  10. Book review

    1. Top of page
    2. Editors’ view
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Pharmacoepidemiology
    8. Therapeutics
    9. Adverse drug effects
    10. Short reports
    11. Book review
    12. Letters to the editors
    1. You have free access to this content
  11. Letters to the editors

    1. Top of page
    2. Editors’ view
    3. Review
    4. Pharmacodynamics
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Pharmacoepidemiology
    8. Therapeutics
    9. Adverse drug effects
    10. Short reports
    11. Book review
    12. Letters to the editors
    1. You have free access to this content
      Statins, lack of energy and ubiquinone (pages 606–607)

      Marcus M. Reidenberg

      Version of Record online: 2 MAR 2005 | DOI: 10.1111/j.1365-2125.2005.02359.x

    2. You have free access to this content
      Brugada-like ECG abnormalities during thioridazine overdose (page 608)

      R. Copetti, A. Proclemer and P. P. Pillinini

      Version of Record online: 2 MAR 2005 | DOI: 10.1111/j.1365-2125.2005.02362.x

      • image
    3. You have free access to this content
    4. You have free access to this content

SEARCH

SEARCH BY CITATION